News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Five Prime Therapeutics, Inc. (FPRX) Stock Soars After $62 Million IPO


9/18/2013 9:20:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Five Prime Therapeutics stock debuted with a double digit jump in early Nasdaq trading Wednesday after it raised $62 million in an IPO that priced in the middle of its target range. The South San Francisco company led by CEO Rusty Williams sold 4.8 million shares at $13, compared to original plans to sell 4 million shares at between $12 and $14. The company develops protein therapeutics for cancers and autoimmune diseases.

Help employers find you! Check out all the jobs and post your resume.

Read at Silicon Valley
Read at RTT News
Read at Nasdaq

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES